Wayne H Winegarden
Commentary
Trump Should Support Effective Drug Policy Reforms Not The MFN Gimmick
The Trump Administration has announced its desire to impose price controls on drugs – officially called a most favored nation (MFN) policy. Essentially, the policy sets the price for the targeted drugs at the lowest price in other industrialized countries. The president’s justification for the MFN is simple: Americans are ...
California
PRI On NPR: California Created Its Budget Woes
Winegarden joins Insight with his perspective on the state’s fiscal priorities and budget challenges. Listen to the entire interview here.
Commentary
Congress Should Not Impose Foreign Price Controls On Innovative Drugs
Simple and neat solutions are alluring but often wrong. A case in point is President Trump’s proposal to adopt a most favored nation (MFN) policy. The MFN sets Medicaid’s price for a drug at the lowest price charged in other developed countries each of which has price controls on drugs. ...
Commentary
Deregulation Is The Pathway To Greater Pharmaceutical Innovation
Surveys confirm that most Americans recognize the value of prescription drugs. But the same surveys also show that Americans are worried that they will be unable to afford needed medicines. These conflicting feelings exemplify the inherent tension when it comes to prescription drugs – how do we incentivize innovation to ...
Commentary
The Private Sector Is Setting The PACE For Managed Care
Rising demand for long-term care is inevitable as more and more baby boomers retire. Meeting this demand will be a challenge. Recent evidence from the PACE program demonstrates that for-profit care providers can help meet this growing demand, but only if the regulatory environment allows it. Read the op-ed here.
Business & Economics
An economist explains what trade deficits really mean
Believing the myth that trade deficits are bad, the Trump Administration imposed global reciprocal tariffs this week. The proposal threatens to derail economic prosperity and trigger a barn burner of a recession. The fallacy of this myth can be clearly seen in the U.S. economic data. Over the last half-century ...
Business & Economics
Louisiana Is Litigating Away Its Economic Prosperity
Numerous Louisiana parishes are suing oil and gas companies over coastal erosion. A Plaquemines Parish courtroom has a front row seat to one of the more high-dollar cases taking place where the plaintiffs have reportedly asked for more than $3 billion in damages from just one of the defendants. Undoubtedly ...
Business & Economics
Reversing Regulatory Overreach Will Encourage Payment Innovations
Innovation is often a victim of its own success as the once unimaginable becomes the invaluable service people cannot live without. The modern payments system exemplifies this phenomenon. Innovations by fintech startups as well as traditional financial companies now enable trillions of dollars in transactions annually. And thanks to robust ...
Drug Prices
New Brief: ‘Maximum Fair Price’ Policy Would Bring New Costs to Nevada Taxpayers, Put Patient Access to Health Care at Risk
SACRAMENTO – Nevada taxpayers could face millions in new bureaucratic costs and patients will likely see less access to life-saving drugs if state government mandates so-called “Maximum Fair Price” price controls on prescription drugs, finds a new brief released today by the Center for Medical Economics and Innovation at the ...
Business & Economics
Robust Tech Company Investment Show The Folly Of Trump’s Tariffs
On February 24th, Apple announced that, over the next four years, the company will invest $500 billion into U.S. advanced manufacturing and high-tech initiatives such as artificial intelligence and silicon engineering. Additionally, the company expects to hire 20,000 people over this time frame. These investments will make important contributions to ...
Trump Should Support Effective Drug Policy Reforms Not The MFN Gimmick
The Trump Administration has announced its desire to impose price controls on drugs – officially called a most favored nation (MFN) policy. Essentially, the policy sets the price for the targeted drugs at the lowest price in other industrialized countries. The president’s justification for the MFN is simple: Americans are ...
PRI On NPR: California Created Its Budget Woes
Winegarden joins Insight with his perspective on the state’s fiscal priorities and budget challenges. Listen to the entire interview here.
Congress Should Not Impose Foreign Price Controls On Innovative Drugs
Simple and neat solutions are alluring but often wrong. A case in point is President Trump’s proposal to adopt a most favored nation (MFN) policy. The MFN sets Medicaid’s price for a drug at the lowest price charged in other developed countries each of which has price controls on drugs. ...
Deregulation Is The Pathway To Greater Pharmaceutical Innovation
Surveys confirm that most Americans recognize the value of prescription drugs. But the same surveys also show that Americans are worried that they will be unable to afford needed medicines. These conflicting feelings exemplify the inherent tension when it comes to prescription drugs – how do we incentivize innovation to ...
The Private Sector Is Setting The PACE For Managed Care
Rising demand for long-term care is inevitable as more and more baby boomers retire. Meeting this demand will be a challenge. Recent evidence from the PACE program demonstrates that for-profit care providers can help meet this growing demand, but only if the regulatory environment allows it. Read the op-ed here.
An economist explains what trade deficits really mean
Believing the myth that trade deficits are bad, the Trump Administration imposed global reciprocal tariffs this week. The proposal threatens to derail economic prosperity and trigger a barn burner of a recession. The fallacy of this myth can be clearly seen in the U.S. economic data. Over the last half-century ...
Louisiana Is Litigating Away Its Economic Prosperity
Numerous Louisiana parishes are suing oil and gas companies over coastal erosion. A Plaquemines Parish courtroom has a front row seat to one of the more high-dollar cases taking place where the plaintiffs have reportedly asked for more than $3 billion in damages from just one of the defendants. Undoubtedly ...
Reversing Regulatory Overreach Will Encourage Payment Innovations
Innovation is often a victim of its own success as the once unimaginable becomes the invaluable service people cannot live without. The modern payments system exemplifies this phenomenon. Innovations by fintech startups as well as traditional financial companies now enable trillions of dollars in transactions annually. And thanks to robust ...
New Brief: ‘Maximum Fair Price’ Policy Would Bring New Costs to Nevada Taxpayers, Put Patient Access to Health Care at Risk
SACRAMENTO – Nevada taxpayers could face millions in new bureaucratic costs and patients will likely see less access to life-saving drugs if state government mandates so-called “Maximum Fair Price” price controls on prescription drugs, finds a new brief released today by the Center for Medical Economics and Innovation at the ...
Robust Tech Company Investment Show The Folly Of Trump’s Tariffs
On February 24th, Apple announced that, over the next four years, the company will invest $500 billion into U.S. advanced manufacturing and high-tech initiatives such as artificial intelligence and silicon engineering. Additionally, the company expects to hire 20,000 people over this time frame. These investments will make important contributions to ...
